Patents by Inventor David W. Robertson

David W. Robertson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 3,4-diphenylbutanamines
    Patent number: 4996235
    Abstract: The present invention provides 3,4-diphenylbutanamines capable of selectively inhibiting the uptake of serotonin and norepinephrine.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: February 26, 1991
    Assignee: Eli Lilly and Company
    Inventors: David W. Robertson, David T. Wong
  • Anticonvulsant agents
    Patent number: 4981866
    Abstract: This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: March 27, 1990
    Date of Patent: January 1, 1991
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Anticonvulsant agents
    Patent number: 4973597
    Abstract: This invention provides certain pyridinecarboxamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: June 30, 1989
    Date of Patent: November 27, 1990
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • 3-aryloxy-3-substituted propanamines
    Patent number: 4956388
    Abstract: The present invention provides 3-aryloxy-3-substituted propanamines capable of inhibiting the uptake of serotonin and norepinephrine.
    Type: Grant
    Filed: January 12, 1990
    Date of Patent: September 11, 1990
    Assignee: Eli Lilly and Company
    Inventors: David W. Robertson, David T. Wong, Joseph H. Krushinski, Jr.
  • Anticonvulsant agents
    Patent number: 4939163
    Abstract: This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: April 10, 1989
    Date of Patent: July 3, 1990
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Antiarrhythmic method
    Patent number: 4931470
    Abstract: This invention provides a method of treating or preventing cardiac arrhythmias employing certain 4-amino-N-2,6-(dimethylphenyl)benzamide derivatives.
    Type: Grant
    Filed: December 27, 1988
    Date of Patent: June 5, 1990
    Assignee: Eli Lilly and Company
    Inventors: Donald R. Holland, David W. Robertson
  • 5-halo-2,3-dihydro-2,2-dimethylbenzofuran-7-carboxylic acids useful as intermediates for 5-HT.sub.3 antagonists
    Patent number: 4921982
    Abstract: This invention provides bicyclic carboxylic esters and amides, their pharmaceutical formulations, and a method for their use in treating migraine, emesis, gastrointestinal disorders, schizophrenia, or anxiety in mammals.
    Type: Grant
    Filed: June 14, 1989
    Date of Patent: May 1, 1990
    Assignee: Eli Lilly and Company
    Inventors: Marlene L. Cohen, William B. Lacefield, David W. Robertson
  • Method for treating gastrointestinal disorders
    Patent number: 4920102
    Abstract: Novel ring-contracted macrolides which enhance gastrointestinal motility and novel methods and compositions for treating gtastrointestinal disorders in animals with these macrolides and with certain other previously known ring-contracted macrolides are provided.
    Type: Grant
    Filed: April 18, 1988
    Date of Patent: April 24, 1990
    Assignee: Eli Lilly and Company
    Inventors: Jaswant S. Gidda, Herbert A. Kirst, David W. Robertson
  • 2-phenylimidazo[4,5-c]pyridines
    Patent number: 4904785
    Abstract: This invention provides for certain 2-phenylimidazo[4,5-c]pyridines, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.
    Type: Grant
    Filed: May 2, 1988
    Date of Patent: February 27, 1990
    Assignee: Eli Lilly and Company
    Inventors: David W. Robertson, J. Scott Hayes
  • Heteroalkylamides of (8-.beta.)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT.sub.2 receptors
    Patent number: 4902691
    Abstract: This invention provides (8.beta.)-N-heteroalkyl-1-alkyl-6-(substituted)ergoline-8-carboxamides useful for blocking 5HT.sub.2 receptors in mammals having an excess of serotonin centrally or peripherally. The invention also provides methods for treating sexual dysfunction, hypertension, migraine, vasospasm, thrombosis, ischemia, depression, anxiety, sleep disorders and appetite disorders with a compound of the invention.
    Type: Grant
    Filed: December 19, 1988
    Date of Patent: February 20, 1990
    Assignee: Eli Lilly and Company
    Inventors: Marlene L. Cohen, David W. Robertson
  • 1-Phenylalkylamines as selective serotonin uptake inhibitors
    Patent number: 4876282
    Abstract: The present invention provides 1-phenyl-(naphthalenyl)alkylamines which are selective inhibitors of serotonin uptake.
    Type: Grant
    Filed: November 25, 1987
    Date of Patent: October 24, 1989
    Assignee: Eli Lilly and Company
    Inventors: David W. Robertson, David T. Wong
  • Anticonvulsant agents using cyano dimethylphenyl benzamides
    Patent number: 4835181
    Abstract: This invention provides certain 4-substituted benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: February 18, 1987
    Date of Patent: May 30, 1989
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • 2-phenylimidazio (4,5-c) pyridines
    Patent number: 4758574
    Abstract: This invention provides for certain 2-phenylimidazo[4,5-c]pyridines, their pharmaceutical formulations, and their use as positive inotropic agents, bronchodilators, vasodilators, and anticoagulants.
    Type: Grant
    Filed: June 26, 1986
    Date of Patent: July 19, 1988
    Assignee: Eli Lilly and Company
    Inventors: David W. Robertson, J. Scott Hayes
  • Anticonvulsant agents
    Patent number: 4684748
    Abstract: This invention provides certain benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: July 26, 1985
    Date of Patent: August 4, 1987
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Inotropic agents
    Patent number: 4647564
    Abstract: This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.
    Type: Grant
    Filed: March 5, 1986
    Date of Patent: March 3, 1987
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Intermediates for anticonvulsant agents
    Patent number: 4642379
    Abstract: This invention provides certain 4-acylamino benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
    Type: Grant
    Filed: August 30, 1985
    Date of Patent: February 10, 1987
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • Anticonvulsant agents
    Patent number: 4632939
    Abstract: This invention provides certain benzamide derivatives of the formula: ##STR1## wherein Z is bond, --CH.sub.2 --, or CHCH.sub.3 ; A is --CH.sub.2 --, or CH.sub.2 CH.sub.2 --; and represents a single or double bond; and their pharmaceutical formulations and their use as anticonvulsant agents.
    Type: Grant
    Filed: March 15, 1985
    Date of Patent: December 30, 1986
    Assignee: Eli Lilly and Company
    Inventors: Edward E. Beedle, David W. Robertson
  • 6-(pyridinylphenyl)dihydropyridazinones as inotropic agents
    Patent number: 4631279
    Abstract: This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.
    Type: Grant
    Filed: October 15, 1984
    Date of Patent: December 23, 1986
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Anticonvulsant agents
    Patent number: 4629740
    Abstract: This invention provides for certain benzamide derivatives and their pharmaceutical formulations and their use as anticonvulsant agents.
    Type: Grant
    Filed: April 10, 1984
    Date of Patent: December 16, 1986
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson
  • Inotropic agents
    Patent number: 4617302
    Abstract: This invention provides certain pyridazinone derivatives, their pharmaceutical formulations, and their use as positive inotropic agents.
    Type: Grant
    Filed: October 15, 1984
    Date of Patent: October 14, 1986
    Assignee: Eli Lilly and Company
    Inventor: David W. Robertson